Latest Marketable Securities News

Dexus (ASX: DXS) reported steady FY26 results with AFFO of 45.0 cents per security and distributions of 37.0 cents, while initiating a strategic review of infrastructure funds following an adverse APAC court judgment.

Energy Fuels Inc. reported a transformative 2024 with a major acquisition boosting its heavy mineral sands assets, a uranium production ramp-up at key US mines, and commercial rare earth oxide output from its White Mesa Mill.

Novo Resources has progressed its Belltopper Gold Project with a planned diamond drilling campaign and completed maiden Pilbara drilling programs, while reporting a $3.9 million net loss for H1 2026 and bolstering liquidity through capital raises.

EBR Systems marked a commercial milestone with over 100 WiSE CRT implants and secured purchasing agreements with three major US healthcare networks. The company is progressing toward Medicare coverage and scaling manufacturing, supported by a near-complete A$150 million capital raise.

Dexus Industria REIT (ASX:DXI) delivered FY26 funds from operations (FFO) per security above upgraded guidance, driven by robust leasing spreads, active portfolio management, and a growing development pipeline.

Dexus Convenience Retail REIT (ASX:DXC) delivered FY26 distributions of 20.9 cents per security, matching guidance amid resilient income growth and portfolio enhancement.

Imricor Medical Systems has ignited its US commercial operations with rapid adoption by top pediatric hospitals, buoyed by FDA pediatric clearances and clinical trial progress.

AVITA Medical posted robust Q2 2026 results with 18% revenue growth, driven by RECELL and supported by Cohealyx and PermeaDerm, and now expects to reach cash flow breakeven by year-end.

Block, Inc. delivered a robust Q2 2026 with 25% gross profit growth, driven by strong Cash App and Square performances, and raised its full-year guidance reflecting accelerating AI integration and hardware innovation.

DXN Limited has landed a $1.2 million contract for a key Pacific submarine cable project while advancing its maiden AI HPC modular data centre deal and expanding manufacturing in Southeast Asia.

Memphasys has rapidly established a foothold in the UK IVF market, securing four active commercial trials and initial orders for its Felix™ sperm selection system within weeks of launch. This momentum aligns with its global expansion strategy targeting major fertility markets.

Dexus Convenience Retail REIT reports a 1.1% net valuation uplift for H1 2026 and increases its on-market buy-back target to 5% of securities, signalling confidence in its portfolio and capital management.